Correction: Kudura et al. Prediction of Early Response to Immune Checkpoint Inhibition Using FDG-PET/CT in Melanoma Patients. Cancers 2021, 13, 3830

Affiliations

¹ Department of Nuclear Medicine, University Hospital Zurich, 8091 Zurich, Switzerland.
² Department of Dermatology, University Hospital Zurich, 8091 Zurich, Switzerland.
³ Center for Proton Therapy, Paul Scherrer Institute, 5232 Villigen, Switzerland.
⁴ Institute of Radiation Oncology, Cantonal Hospital Winterthur, 8400 Winterthur, Switzerland.
⁵ Institute of Pathology and Molecular Pathology, University Hospital Zurich, 8091 Zurich, Switzerland.
⁶ Faculty of Applied Statistics, Humboldt University Berlin, 10117 Berlin, Germany.
⁷ Department of Nuclear Medicine, Cantonal Hospital Baden, 5404 Baden, Switzerland.
⁸ Department of Radiology and Nuclear Medicine, Division of Nuclear Medicine, University Hospital Magdeburg, 39120 Magdeburg, Germany.

Published Erratum

Ken Kudura et al. Cancers (Basel). 2022.

. 2022 Jul 4;14(13):3268.

doi: 10.3390/cancers14133268.

¹ Department of Nuclear Medicine, University Hospital Zurich, 8091 Zurich, Switzerland.
² Department of Dermatology, University Hospital Zurich, 8091 Zurich, Switzerland.
³ Center for Proton Therapy, Paul Scherrer Institute, 5232 Villigen, Switzerland.
⁴ Institute of Radiation Oncology, Cantonal Hospital Winterthur, 8400 Winterthur, Switzerland.
⁵ Institute of Pathology and Molecular Pathology, University Hospital Zurich, 8091 Zurich, Switzerland.
⁶ Faculty of Applied Statistics, Humboldt University Berlin, 10117 Berlin, Germany.
⁷ Department of Nuclear Medicine, Cantonal Hospital Baden, 5404 Baden, Switzerland.
⁸ Department of Radiology and Nuclear Medicine, Division of Nuclear Medicine, University Hospital Magdeburg, 39120 Magdeburg, Germany.

Abstract

The authors wish to make the following corrections to this paper [...].

Prediction of Early Response to Immune Checkpoint Inhibition Using FDG-PET/CT in Melanoma Patients.
Kudura K, Dimitriou F, Basler L, Förster R, Mihic-Probst D, Kutzker T, Dummer R, Mangana J, Burger IA, Kreissl MC. Kudura K, et al. Cancers (Basel). 2021 Jul 29;13(15):3830. doi: 10.3390/cancers13153830. Cancers (Basel). 2021. PMID: 34359730 Free PMC article.

1. Kudura K., Dimitriou F., Basler L., Förster R., Mihic-Probst D., Kutzker T., Dummer R., Mangana J., Burger I.A., Kreissl M.C. Prediction of Early Response to Immune Checkpoint Inhibition Using FDG-PET/CT in Melanoma Patients. Cancers. 2021;13:3830. doi: 10.3390/cancers13153830. - DOI - PMC - PubMed
1. Basler L., Gabryś H.S., Hogan S.A., Pavic M., Bogowicz M., Vuong D., Tanadini-Lang S., Förster R., Kudura K., Huellner M.W., et al. Radiomics, Tumor Volume, and Blood Biomarkers for Early Prediction of Pseudoprogression in Patients with Metastatic Melanoma treated with Immune Checkpoint Inhibition. Clin. Cancer Res. 2020;26:4414–4425. doi: 10.1158/1078-0432.CCR-20-0020. - DOI - PubMed